COVID-19 Vaccine in Patients with Exacerbation of Idiopathic Pulmonary Fibrosis

Am J Respir Crit Care Med. 2022 Jul 15;206(2):219-221. doi: 10.1164/rccm.202112-2765LE.

Authors

Giacomo Sgalla¹, Tonia Magrì², Marialessia Lerede², Alessia Comes², Luca Richeldi^{2

3}

Affiliations

¹ Fondazione Policlinico Universitario A. Gemelli Istituto di Ricovero e Cura a Carattere Scientifico Rome, Italy.
² Università Cattolica del Sacro Cuore Rome, Italy.
³ Fondazione Policlinico Universitario A. Gemelli Istituto di Ricovero e Cura a Carattere Scientifico.

No abstract available

Publication types

Letter

MeSH terms

Acute Disease
COVID-19 Vaccines
COVID-19*
Disease Progression
Humans
Idiopathic Pulmonary Fibrosis*

Substances

COVID-19 Vaccines